Clinical Trial Update: Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of the fixed-dose combination aliskiren/amlodipine/hydrochlorothiazide in moderate-to-severe hypertension has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amturnide (aliskiren/amlodipine/hydrochlorothiazide)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-05-09